Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 216,312 | 288,586 | 124,984 | 32,778 | -6,836 |
| Depreciation Amortization | 86,681 | 74,229 | 7,827 | 8,711 | 9,097 |
| Income taxes - deferred | -10,097 | -113,862 | 0 | 0 | N/A |
| Accounts receivable | -48,846 | -4,724 | -12,293 | -9,768 | -5,670 |
| Accounts payable and accrued liabilities | 5,089 | -7,286 | 2,080 | 891 | -3,578 |
| Other Working Capital | -80,958 | -5,157 | -3,652 | -5,707 | -26,920 |
| Other Operating Activity | 120,250 | 17,966 | 32,650 | 31,963 | 18,029 |
| Operating Cash Flow | $288,431 | $249,752 | $151,596 | $58,868 | $-15,878 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 75,791 | -75,853 | 0 | 1,004 |
| PPE Investments | -9,976 | -5,976 | -1,279 | -731 | -53 |
| Net Acquisitions | N/A | -448,609 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -6,288 | -16,500 | -4,500 | -4,000 | -6,000 |
| Other Investing Activity | -6,288 | -16,500 | -4,100 | -1,412 | -7,075 |
| Investing Cash Flow | $-16,264 | $-395,294 | $-81,232 | $-2,143 | $-6,124 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 5,524 |
| Debt Issued | 553,425 | 450,916 | 0 | 48,427 | 0 |
| Debt Repayment | -465,910 | -11,875 | -41,668 | -127,828 | 0 |
| Common Stock Issued | 30,703 | 25,003 | 16,419 | 62,408 | 7,170 |
| Common Stock Repurchased | -136,484 | 0 | 0 | N/A | N/A |
| Other Financing Activity | -5,590 | -15,514 | -7,833 | -10,533 | 0 |
| Financing Cash Flow | $-23,856 | $448,530 | $-33,082 | $-27,526 | $12,694 |
| Exchange Rate Effect | 997 | 2,132 | 0 | 0 | N/A |
| Beginning Cash Position | 387,196 | 82,076 | 44,794 | 15,595 | 24,903 |
| End Cash Position | 636,504 | 387,196 | 82,076 | 44,794 | 15,595 |
| Net Cash Flow | $249,308 | $305,120 | $37,282 | $29,199 | $-9,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | 288,431 | 249,752 | 151,596 | 58,868 | -15,878 |
| Capital Expenditure | -9,976 | -5,976 | -1,279 | -731 | -53 |
| Free Cash Flow | 278,455 | 243,776 | 150,317 | 58,137 | -15,931 |